Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monotherapy with valproate in primary generalized epilepsies.

B Bourgeois1, A Beaumanoir, B Blajev

  • 1Swiss Epilepsy Center, Zurich.

Epilepsia
|January 1, 1987
PubMed
Summary

Sodium valproate monotherapy effectively controls primary generalized epilepsies, with 83% of patients becoming seizure-free. This epilepsy treatment shows significant efficacy across various seizure types and is well-tolerated, with mild side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invasive tree cover covaries with environmental factors to explain the functional composition of riparian plant communities.

Oecologia·2021
Same author

Achieving discharge within 24 h of robotic unicompartmental knee arthroplasty may be possible with appropriate patient selection and a multi-disciplinary team approach.

Journal of orthopaedics·2020
Same author

<i>'Rothia nasisuis'</i> sp. nov., <i>'Dermabacter porcinasus'</i> sp. nov., <i>'Propionibacterium westphaliense'</i> sp. nov. and <i>'Tessaracoccus nasisuum'</i> sp. nov., isolated from porcine nasal swabs in the Münster region, Germany.

New microbes and new infections·2018
Same author

Human energy expenditure: advances in organ-tissue prediction models.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2018
Same author

Clinically applicable optical imaging technology for body size and shape analysis: comparison of systems differing in design.

European journal of clinical nutrition·2017
Same author

Assessment of human energy exchange: historical overview.

European journal of clinical nutrition·2016

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Primary generalized epilepsies present significant treatment challenges.
  • Many patients require effective monotherapy for seizure control.
  • Prior drug therapies may be limited by efficacy or adverse effects.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of sodium valproate enteric-coated tablets as monotherapy for primary generalized epilepsies.
  • To assess the impact of sodium valproate on seizure frequency and electroencephalogram (EEG) paroxysmal activity.
  • To determine the optimal duration for trialing sodium valproate before considering alternative treatments.

Main Methods:

  • A cohort of 118 patients with primary generalized epilepsies received sodium valproate monotherapy.
  • Patients were followed for a median of 17 months, with dosage adjusted to <20 mg/kg/day.

Related Experiment Videos

  • Seizure control, EEG findings, and adverse events were systematically recorded.

    • Main Results:

    • 83% of patients achieved seizure freedom at a mean daily dosage below 20 mg/kg.
    • High efficacy was observed for tonic-clonic seizures (85%), absences (82%), and myoclonic seizures (82%).
    • EEG paroxysmal activity decreased from 88% to 32.4%, and side effects were mild and transient in 16% of patients initially, decreasing to 2%.

    Conclusions:

    • Sodium valproate monotherapy is a highly effective treatment for primary generalized epilepsies.
    • The drug demonstrates broad-spectrum efficacy against major seizure types and improves EEG findings.
    • Adequate trial periods are crucial for maximizing the benefits of sodium valproate before switching medications.